From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics.

Saved in:
Bibliographic Details
Title: From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics.
Authors: Di Pierro F; Microbiota International Clinical Society, Turin, Italy. f.dipierro@vellejaresearch.com.; Scientific and Research Department, Velleja Research, Milan, Italy. f.dipierro@vellejaresearch.com.; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy. f.dipierro@vellejaresearch.com., Thacharodi A; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA., Kumaraswami M; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA., Suvorov A; Federal State Budgetary Scientific Institution Institute of Experimental Medicine, St. Petersburg, Russia., Zupet J; Eustone Research Center, Ljubljana, Slovenia., Zerbinati N; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.
Source: Microbial cell factories [Microb Cell Fact] 2026 Apr 13; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2859 (Electronic) Linking ISSN: 14752859 NLM ISO Abbreviation: Microb Cell Fact Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1475-2859
DOI:10.1186/s12934-026-02997-w